Modernizing bp’s application landscape with AI – Go Health Pro

Modernizing bp’s application landscape with AI – Go Health Pro

One of the oldest and largest oil and gas companies in the world, bp is in the midst of a major transition as it pivots toward becoming an integrated energy company. As part of this transition, the company is aiming for a net-zero carbon footprint by 2050. The scope of its efforts so far is … Read more

Continued broad application in 2024 – Go Health Pro

Continued broad application in 2024 – Go Health Pro

Happy New Year to all our Readers! A couple of posts ago we have commented on the changes that the Compass Banca judgment may bring to the average consumer benchmark (see “Who is the average consumer?…”), although we will need to carefully follow the practical application of this judgment by national courts. Still, it was reassuring … Read more

How a voting advice application influenced the 2024 European Parliament election – Go Health Pro

How a voting advice application influenced the 2024 European Parliament election – Go Health Pro

Do voting advice applications work? Drawing on a new field experiment during the 2024 European Parliament election, Joris Frese, Simon Hix and Romain Lachat find that while there is limited evidence voting advice applications boost turnout levels, their recommendations do appear to have a meaningful impact on the choices made by voters. Voting advice applications … Read more

the risky proposition of extending the application of the EU Temporary Protection Directive beyond March 2025 – Go Health Pro

the risky proposition of extending the application of the EU Temporary Protection Directive beyond March 2025 – Go Health Pro

    Dr Meltem Ineli-Ciger, Associate Professor, Suleyman Demirel University Faculty of Law; Migration Policy Centre Associate, European University Institute   Photo credit: Falin, on Wikimedia Commons   What should follow once the deadline for the application of the Council Directive 2001/55/EC of 20 July 2001 (Temporary Protection Directive) to those fleeing the invasion of … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDA – Go Health Pro

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT DrugSorb-ATR Submission On October 1, 2024, CytoSorbents (NASDAQ:CTSO) announced the submission of its DrugSorb-ATR medical device De Novo marketing application to the U.S. Food and Drug Administration (FDA) on September 27, 2024. The goal of this product is to reduce the severity of perioperative … Read more

x